Erudio Healtherudio.com
Sponsor
Sanofi trials: what clinicians said in public
No HCP commentary report on a trial sponsored by Sanofi yet. Erudio has found public clinician commentary on 11 clinical trials sponsored by Sanofi, including CARMEN-LC03, ICARIA-MM, IKEMA and IRAKLIA. Each trial's page lists the podcasts, videos and posts found so far and the price of a report.
Listed by lead sponsor as registered on ClinicalTrials.gov (Sanofi). A trial led by a partner or a research group is on that sponsor's page. Only trials with public clinician commentary found are listed, not every trial the sponsor runs.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| IKEMA NCT03275285 · Sanofi DeepView → | relapsed/refractory multiple myeloma | Phase 3 | Deep | View | |||
| IRAKLIA NCT05405166 · Sanofi DeepView → | relapsed/refractory multiple myeloma | Phase 3 | Deep | View | |||
| ICARIA-MM NCT02990338 · Sanofi DeepView → | relapsed and refractory multiple myeloma | Phase 3 | Deep | View | |||
| CARMEN-LC03 NCT04154956 · Sanofi DeepView → | previously treated CEACAM5-positive metastatic nonsquamous non-small-cell lung cancer | Phase 3 | Deep | View | |||
| TROPIC NCT00417079 · Sanofi StandardView → | metastatic castration-resistant prostate cancer after docetaxel treatment | Phase 3 | Standard | View | |||
| IZALCO NCT05704049 · Sanofi StandardView → | relapsed/refractory multiple myeloma | Phase 2 | Standard | View | |||
| CARMEN-LC05 NCT04524689 · Sanofi FocusedView → | CEACAM5-positive advanced/metastatic non-squamous NSCLC | Phase 2 | Focused | View | |||
| NCT02513186 NCT02513186 · Sanofi FocusedView → | newly diagnosed multiple myeloma without immediate transplantation | Phase 1 | Focused | View | |||
| IMROZ NCT03319667 · Sanofi FocusedView → | transplant-ineligible newly diagnosed multiple myeloma | Phase 3 | Focused | View | |||
| NCT02187848 NCT02187848 · Sanofi FocusedView → | advanced solid tumors | Phase 1 | Focused | View | |||
| CARMEN-LC04 NCT04394624 · Sanofi FocusedView → | pretreated CEACAM5-positive metastatic non-squamous non-small cell lung cancer | Phase 2 | Focused | View | |||